To cross $ 1 bn in revenues this year: Dr Reddy’s

Posted by john on July 31st, 2006 — in Allegra Top News

VC & CEO of Dr Reddy’s, GV Prasad, says that they should comfortably cross USD 1 billion in revenues, this year.
Prasad says that the margins on Zocor and Proscar have been very substantial. He also states that acquisitions contributed USD 71 million to revenues in Q1.
Betapharm had a tough quarter as revenues were hit by […]

Chef serves up special menu for allergy sufferers

Posted by john on July 30th, 2006 — in Allegra Top News

When Dominique Tougne slides into the seat across from me at Bistro 110, he is wearing his trademark chef’s jacket and a grin from ear to ear.
Before I even open my notebook, the executive chef of the saucy neighbourhood restaurant located just off the famous Magnificent Mile reaches into his pocket and pulls out his […]

Europeans warm to discount supermarkets

Posted by john on July 28th, 2006 — in Allegra Top News

Discount retailing is still on the rise in Europe, as international expansion and increasing consumer acceptance are set to push sales up 36 per cent by 2010.
According to a new report by Planet Retail, the discount format continues to gain popularity and acceptance, despite a relatively slow start for Aldi, Netto and Lidl when they […]

Merck 2nd-Quarter Net Doubles on Allergy, Cholesterol Pills

Posted by john on July 24th, 2006 — in Allegra Top News

Merck & Co. said second-quarter profit doubled as an increase in prescriptions for allergy and heart-disease drugs helped overcome a drop in sales of the Zocor cholesterol pill.
Net income rose to $1.5 billion, or 69 cents a share, from $720.6 million, or 33 cents, a year earlier, when profit was reduced by costs related to […]

NHS ‘lets down allergy patients

Posted by john on July 20th, 2006 — in Allegra Top News

People with allergies often feel let down by the NHS, and can wait months to see a specialist, a government review of services has found.
The report said charities and other groups were often left to plug the gaps in NHS care.
It said more should be done to help the third of people who are affected […]

Keep Our ‘Addiction/ to Oil, End Our Allergy to Self-Assertion

Posted by john on July 17th, 2006 — in Allegra Top News

Politicians and commentators from both parties are decrying our “addiction to oil.” They exhort us to embrace costly programs to reduce our consumption of oil as quickly as possible. The primary rationale for this is national security. Our oil consumption is dangerous because, in the words of a New York Times editorial, “Oil profits that […]

Small cap round-up: Allergy, Mano River

Posted by john on July 15th, 2006 — in Allegra Top News

Hay fever vaccine developer Allergy Therapeutics expects annual sales to come in at around £23.5m, meeting market forecasts.
It has made excellent progress with its clinical trials programmes throughout the year, it added.
Africa-focused miner Mano River Resources is raising £3m through the issue of 39.6m shares at 8p each.
Eco-friendly packaging group Stanelco’s losses widened to £2.3m […]

Patient with antibiotic allergy dies, nurse blamed

Posted by john on July 12th, 2006 — in Allegra Top News

A Health Ministry investigation committee on Tuesday recommended filing a complaint against a nurse at Haifa’s Rambam Medical Center for giving a 63-year-old woman patient penicillin even though her file and identification bracelet clearly showed she was allergic to the antibiotic.
The woman died from shock after getting the antibiotics by infusion. The committee members said […]

Buy Dr Reddy’s Labs, target of Rs 1836: Merrill Lynch

Posted by john on July 11th, 2006 — in Allegra Top News

Management upbeat on all-round growth and expects to achieve near USD 1 billion revenues for FY07 (USD 542 million in FY06) excluding generic Zocor and Proscar upsides. This compares with MLe revenues of USD 920 million on a like-to-like basis.”
Update on US product upsides in FY07 and FY08
“Over 60% discount to innovator prices for Generic […]

Allergy drug Astemizole can control malarial infection

Posted by john on July 7th, 2006 — in Allegra Top News

U.S. scientist’s reports have found that the allergy drug Astemizole can additionally control malarial infection by hindering with a key process of the parasite.
After taking the blood of its victims the malaria parasite P. falciparum causes the crystallization of heme molecules from it. Some anti-malarials, for example chloroquine, prevent the reaction. However there are strains […]